Specific power calculations for magnetic resonance imaging (MRI) in monitoring active relapsing-remitting multiple sclerosis (MS): implications for phase II therapeutic trials.
Autor: | Truyen, L, Barkhof, F, Tas, M, Van Walderveen, MAA, Frequin, STFM, Hommes, OR, Nauta, JJP, Polman, CH, Valk, J |
---|---|
Zdroj: | Multiple Sclerosis (13524585); Jan1997, Vol. 2 Issue 6, p283-290, 8p |
Databáze: | Complementary Index |
Externí odkaz: |